Home Noticias de Salud Family Centers Health Centers Resources My Health Manager
  Search
  PersonalMD Services  
  Family Health
  Women's Health
  Children's Health
  Men's Health
  Senior's Health
   
  Health Centers
  Alternative Medicine
  Cardiac Care Center
  Cancer Center
  Emergency Dept
  Medical Advances
  Nutrition Central
  Pulmonary Center
  Sports Medicine
  Travel Medicine
   
  Resources
  Drug Interaction
  Drugs & Medications
  Health Encyclopedia


     
   
Newer oral contraceptives just as safe as older types

By Amy Norton

NEW YORK, Aug 18 (Reuters Health) - Despite a 1995 "scare" over the safety of the newest wave of birth control pills, UK researchers now say these concerns were unfounded. So-called 'third generation' pills seem to be no more likely than their previous incarnation to trigger blood clots in women, the investigators report.

Use of third generation contraceptive pills fell sharply in the UK after research suggested they were twice as likely as second generation pills to cause blood clots in the lungs or veins--even though the risk of such clots is still very low among birth control pill users.

However, the decline in the use of third generation pills has created no drop in blood clots among women on the Pill, researchers report in the August 19th issue of the British Medical Journal. The safety of the newest generation of oral contraceptives is "no different than the older ones," lead researcher Dr. Richard D.T. Farmer of the University of Surrey told Reuters Health.

Third and second generation birth control pills differ in the type of progestin they contain. Both generations combine the hormone with low doses of estrogen; second generation oral contraceptives, which were introduced in the late 1970s, contain a synthetic hormone called levonorgestrel, and third generation oral contraceptives contain desogestrel or norgestimate. According to Farmer, the Pill's link to a risk for blood clots was originally attributed to its estrogen content. That came into question, he said, in 1995, when the UK advised women that third generation pills carried a higher risk for blood clots.

Farmer's team found that between 1995 and 1998, use of third generation pills fell from 54% of UK women on the Pill to just 14%. Yet the incidence of blood clots did not follow suit, and in fact rose to a higher-than-expected level. The number of cases--97--was still quite low, however.

These findings, Farmer pointed out, reinforce the belief that the Pill's estrogen level is indeed behind its association with blood clots. This link is one reason today's Pill contains much lower doses of estrogen compared with the first generation of oral contraceptives. The decision about which Pill generation to take should depend on the individual woman, Farmer explained. Some women, for example, may prefer third generation pills because they help clear up acne, he noted. "We now can give women genuine choices," Farmer said, "and one should treat each woman as an individual."


DISCUSSION
See what PersonalMD members have to say about this article.
 

 

 

 

Register About Us Emergency Contact us Privacy Policy Help Center
Resources Health Centers Family Health